| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 0 | 0 | - | - |
| Research and development expense | 888 | 935 | 808 | - |
| General and administrative expense | 1,499 | 1,514 | 2,217 | 1,434 |
| Litigation legal expense | 0 | - | - | 1,138 |
| Loss from sale or disposal of property and equipment | -4 | -60 | - | - |
| Gain on early lease termination | 0 | 0 | 5,974 | - |
| Total operating expenses | 2,391 | 2,509 | -2,949 | 2,572 |
| Operating loss | -2,391 | -2,509 | 2,949 | -2,572 |
| Dividend income | 27 | 52 | 27 | - |
| Interest income | 29 | 4 | 5 | 1 |
| Interest expense | 0 | - | - | 12 |
| Gain on settlement of accounts payables | 155 | 0 | 191 | - |
| Change in fair value of contingent liability | 246 | 159 | 136 | - |
| Other (expense) income, net | -11 | -9 | -26 | 1,500 |
| Total other (expense) income, net | -46 | -112 | 61 | 1,489 |
| Net loss before provision for income taxes | -2,437 | -2,621 | 3,010 | -1,083 |
| Provision for income taxes | 0 | 0 | - | 8 |
| Net loss | -2,437 | -2,621 | 3,010 | -1,091 |
| Basic loss per common share (in dollars per share) | -0.39 | -0.41 | 0.49 | -0.57 |
| Diluted loss per common share (in dollars per share) | -0.39 | -0.41 | 0.49 | -0.57 |
| Weighted-average basic common shares outstanding (in shares) | 6,322,078 | 6,317,744 | 6,172,268 | 1,899,412 |
| Weighted-average diluted common shares outstanding (in shares) | 6,322,078 | 6,317,744 | 6,182,679 | 1,899,412 |
EXICURE, INC. (XCUR)
EXICURE, INC. (XCUR)